Scholar Rock: FDA approves ISEMBYLD; company to conduct pregnancy safety study and report fractures
Scholar Rock announced FDA approval of ISEMBYLD for SMA patients on SMN2-targeted therapy and confirmed plans to meet FDA post—marketing requirements.Key Highlights:Original SEC Filing: Scholar Rock Holding Corp [ SRRK ] - 8-K - Sep. 15, 2026This is an AI-powered summary. It may contain inaccuracie…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.